Fetal Bovine Serum Market Outlook 2031

  • The global fetal bovine serum market was valued at US$ 842.73 Mn in 2020
  • It is estimated to expand at a CAGR of 6.4% from 2021 to 2031
  • The global fetal bovine serum market is expected to surpass the value of US$ 1.6 Bn by the end of 2031

Analysts’ Viewpoint on Fetal Bovine Serum Market Scenario

Increasing application in cell culture, drug discovery, vitro fertilization, and human & animal vaccine production is expected to drive the demand for fetal bovine serum (FBS) globally. Stakeholders in the fetal bovine serum market are driving their revenue by launching advanced cell culture products such as bioreactors, media, reagents, etc. Fetal bovine serum is made from bovine fetuses that are removed from pregnant cows during slaughter. There has been a decline in the production of fetal bovine serum in the past few years due to rising awareness about animal welfare across the globe. However, market players are focusing on innovative methods to increase the production of fetal bovine serum during the forecast period.

Manufacturers Leverage Revenue Opportunities Due to Surging Demand amid Coronavirus Crisis

The fetal bovine serum market is moderately impacted by the COVID-19 pandemic due to lockdowns and closing of several research institutes & manufacturing units. However, there was a rise in demand for fetal bovine serum due to its increasing use in the production of antiviral drugs and vaccines during coronavirus. The growing use of fetal bovine serum in the preparation of vitro cell-culture is driving the demand amid the ongoing COVID-19 pandemic.

Market players and stakeholders have increased the on-demand production and supply of fetal bovine serum to grab incremental opportunities. Moreover, surging demand for effective vaccines for reducing the impact of the COVID-19 infection has created potential revenue opportunities for manufacturers. Academic and industrial researchers, and scientists use fetal bovine serum (FBS) in their cell culture media for biotechnology research, vaccine manufacturing & production, and cloning & animal diagnostics.

Request a sample to get extensive insights into the Fetal Bovine Serum Market

Increase in Support from Governments to Boost R&D in Pharmaceutical Sector

Fetal bovine serum is used as a raw material for research activities carried out in pharmaceutical organizations. The growing number of biotechnology, pharmaceutical, and diagnostics companies demand high fetal bovine serum for use. Furthermore, governments of various developing countries are supporting these research activities of pharmaceutical and biotechnology companies across the globe. The increasing awareness about the nutritional advantages of fetal bovine serum is fueling the growth of the fetal bovine serum market. Fetal bovine serum consists of various macromolecular factors, amino acids, sugars, lipids, and hormones that are necessary for cell growth.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Rise in Usage of FBS in Biopharmaceuticals to Drive Global Market

The flourishing growth and development of biopharmaceutical companies is a significant factor contributing to the fetal bovine serum market growth. The use of fetal bovine serum as a growth supplement for in vitro culture system of eukaryotic cells is rising. The fetal bovine serum regulates cell membrane permeability and serves as a carrier for lipids, enzymes, and micronutrients into the cell. Technological advancement in biopharmaceuticals, innovative drug development process, and rising applications in cost-effective personalized medicine are some of the major factors driving the demand for biologics. Biomolecules are increasingly being used for the effective treatment of various diseases in healthcare companies. Biopharmaceutical companies are gaining attention due to the substantial investments and innovative manufacturing practices.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Fetal Bovine Serum Market

Incremental Opportunities for Market Players in North America

Since fetal bovine serum is an important component of cell culture media, its demand is increasing in North America. This nutrient-rich fluid is used in applications such as eukaryotic cell culture. North America is projected to account for the largest share of the global fetal bovine serum market during the forecast period. Expansion of biotechnology sector and increase in the number of pharmaceutical companies and research & development institutes in U.S. and Canada are driving the demand for fetal bovine serum for research and development of new drugs.

Ethical Issues Affecting Fetal Bovine Serum Market

One of the key factor affecting the growth of the fetal bovine serum market is the ethical issues of using animal products. Awareness about animal safety and the number of animal activists in developing countries are rising. Fetal bovine serum is produced from pregnant cows during slaughter. This process is without giving a proper anesthesia to fetuses, causing intense pain and discomfort to them. Thus, several regions are started to use synthetic alternatives to FBS. In addition, rising complexities and technical issues associated with the use of FBS in cell culture are negatively affecting the market growth during the forecast period.

Fetal Bovine Serum Market: Overview

  • Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin, and clotting factors, containing a large number of nutritional and macromolecular factors essential for cell growth
  • Bovine serum albumin is a major component of FBS. Growth factors in FBS are essential for the maintenance and growth of cultured cells. FBS also contains small molecules such as amino acids, sugars, lipids, and hormones.
  • Fetal bovine serum is a major raw material, which is used in biotechnology, pharmaceutical, diagnostics, and veterinary industries. Hence, demand for this serum is increasing, as majority of existing and new pharmaceutical, biotechnology, diagnostics, and veterinary companies focus on research & development and rely on fetal bovine serum due to its proven effectiveness and safety.

Fetal Bovine Serum Market: Drivers

  • The number of pharmaceutical companies is increasing across the globe. These companies focus on research & development activities. Various government initiatives support these activities of pharmaceutical & biotechnology industries. Therefore, demand for fetal bovine serum is increasing, as it is a raw material and even suppliers have not been able to meet the demand for fetal bovine serum due to shortage in bovine serum blood. This has led to rise in the prices of fetal bovine serum.
  • Various governments are collaborating and providing support to pharmaceutical industries or other academic research institutes for research requirements. This boosts the growth of the market.

Fetal Bovine Serum Market: Segmentation

  • In terms of application, the global fetal bovine serum market has been classified drug discovery, cell media culture, in vitro fertilization, human & animal vaccine production, diagnostics, and others
  • Based on end-user, the global fetal bovine serum market has been divided into research & academic institutes, industry (pharma, biotech, etc.), and healthcare facilities
  • Each of the segments has been analyzed in detail for product trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The fetal bovine serum market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Fetal Bovine Serum Market: Regional Overview

  • In terms of region, the global fetal bovine serum market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • North America accounted for the largest share of the global fetal bovine serum market in 2020, and the trend is projected to continue during the forecast period. Growth of the fetal bovine serum market in the region can be primarily ascribed to significant healthcare expenditure, early availability of technologically advanced products, increase in geriatric population, and presence of a large number of fetal bovine serum manufacturers.
  • Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the fetal bovine serum market in the region.
  • The current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2017 to 2031, along with CAGRs for the period from 2021 to 2031
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which are estimated to help new companies willing to enter the market and existing companies to increase market share and in the decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the global fetal bovine serum market
  • Leading players analyzed in the report are
    • ANZCO Foods (Bovogen Biologicals Pvt. Ltd.)
    • ATCC
    • Bio-techne (Atlanta Biologicals)
    • Captivate Bio
    • Danaher (Cytiva)
    • HiMedia Laboratories
    • Merck KGaA
    • PAN Biotech GmbH
    • Rocky Mountain Biologicals
    • TCS Biosciences Ltd.
    • Thermo Fisher Scientific
    • Zen-Bio, Inc.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Fetal Bovine Serum Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 842.73 Mn

Market Forecast Value in 2031

US$ 1,647.47 Mn

Growth Rate (CAGR)

6.4%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Application
    • Drug Discovery
    • Cell Media Culture
    • In Vitro Fertilization
    • Human & Animal Vaccine Production
    • Diagnostic
    • Others
  • End-user
    • Research & Academic Institutes
    • Industry
    • Healthcare Facilities.

Regions Covered

  • North America
  •  Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • U.K.
  • France
  • Italy
  • Germany
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • South Africa
  • GCC Countries
  • Rest of Middle East & Africa

Companies Profiled

  • ANZCO Foods (Bovogen Biologicals Pvt. Ltd.)
  • ATCC
  • Bio-techne (Atlanta Biologicals, Inc.)
  • Captivate Bio
  • Danaher (Cytiva)
  • HiMedia Laboratories
  • Merck KGaA
  • Pan Biotech GmbH
  • Rocky Mountain Biologicals
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific, Inc.
  • Zen-Bio, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Fetal Bovine Serum Market – Segmentation

TMR’s study on the global fetal bovine serum market includes information divided into three segments: application, end-user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global fetal bovine serum market is discussed in detail.

Application
  • Drug Discovery
  • Cell Media Culture
  • In Vitro Fertilization
  • Human & Animal vaccine production
  • Diagnostics
  • Others
End-user
  • Research & Academic Institutes
  • Industry (Pharma, Biotech, etc.)
  • Healthcare Facilities
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Fetal bovine serum market is expected to surpass the value of US$ 1.6 Bn by the end of 2031

Fetal bovine serum market to expand at a CAGR of 6.4% from 2021 to 2031

Fetal bovine serum market is driven by rise in demand for fetal bovine as a raw material by number of pharmaceutical & biotech companies for vaccines for human and animals.

North America accounted for the largest share of the global fetal bovine serum market, and the trend is projected to continue during the forecast period

Key players in the global fetal bovine serum market market include Merck ATCC, Bio-techne (Atlanta Biologicals), Captivate Bio, Danaher (Cytiva), HiMedia Laboratories

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fetal Bovine Serum Market

4. Market Overview

    4.1. Introduction

        4.1.1. Application Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Fetal Bovine Serum Market Analysis and Forecast, 2017-2031

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.2. Pipeline Analysis

    5.3. Regulatory scenario, by Region/Globally

    5.4. Covid-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Fetal Bovine Serum Market Analysis and Forecast, by Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Application, 2017-2031

        6.3.1. Drug Discovery

        6.3.2. Cell Media Culture

        6.3.3. In Vitro Fertilization

        6.3.4. Human & Animal Vaccine Production

        6.3.5. Diagnostics

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Application

7. Global Fetal Bovine Serum Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017-2031

        7.3.1. Research & Academic Institutes

        7.3.2. Industry (pharma, biotech, etc.)

        7.3.3. Healthcare Facilities

    7.4. Market Attractiveness Analysis, by End-user

8. Global Fetal Bovine Serum Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Fetal Bovine Serum Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Application, 2017-2031

        9.2.1. Drug Discovery

        9.2.2. Cell Media Culture

        9.2.3. In Vitro Fertilization

        9.2.4. Human & Animal Vaccine Production

        9.2.5. Diagnostics

        9.2.6. Others

    9.3. Market Value Forecast, by End-user, 2017-2031

        9.3.1. Research & Academic Institutes

        9.3.2. Industry (pharma, biotech, etc.)

        9.3.3. Healthcare Facilities

    9.4. Market Value Forecast, by Country, 2017-2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Application

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Fetal Bovine Serum Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Application, 2017-2031

        10.2.1. Drug Discovery

        10.2.2. Cell Media Culture

        10.2.3. In Vitro Fertilization

        10.2.4. Human & Animal Vaccine Production

        10.2.5. Diagnostics

        10.2.6. Others

    10.3. Market Value Forecast, by End-user, 2017-2031

        10.3.1. Research & Academic Institutes

        10.3.2. Industry (pharma, biotech, etc.)

        10.3.3. Healthcare Facilities

    10.4. Market Value Forecast, by Country/Sub-region, 2017-2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Application

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Fetal Bovine Serum Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Application, 2017-2031

        11.2.1. Drug Discovery

        11.2.2. Cell Media Culture

        11.2.3. In Vitro Fertilization

        11.2.4. Human & Animal Vaccine Production

        11.2.5. Diagnostics

        11.2.6. Others

    11.3. Market Value Forecast, by End-user, 2017-2031

        11.3.1. Research & Academic Institutes

        11.3.2. Industry (pharma, biotech, etc.)

        11.3.3. Healthcare Facilities

    11.4. Market Value Forecast, by Country/Sub-region, 2017-2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Application

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America Fetal Bovine Serum Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Application, 2017-2031

        12.2.1. Drug Discovery

        12.2.2. Cell Media Culture

        12.2.3. In Vitro Fertilization

        12.2.4. Human & Animal Vaccine Production

        12.2.5. Diagnostics

        12.2.6. Others

    12.3. Market Value Forecast, by End-user, 2017-2031

        12.3.1. Research & Academic Institutes

        12.3.2. Industry (pharma, biotech, etc.)

        12.3.3. Healthcare Facilities

    12.4. Market Value Forecast, by Country/Sub-region, 2017-2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Application

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Fetal Bovine Serum Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Application, 2017-2031

        13.2.1. Drug Discovery

        13.2.2. Cell Media Culture

        13.2.3. In Vitro Fertilization

        13.2.4. Human & Animal Vaccine Production

        13.2.5. Diagnostics

        13.2.6. Others

    13.3. Market Value Forecast, by End-user, 2017-2031

        13.3.1. Research & Academic Institutes

        13.3.2. Industry (pharma, biotech, etc.)

        13.3.3. Healthcare Facilities

    13.4. Market Value Forecast, by Country/Sub-region, 2017-2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Application

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix

    14.2. Market Share Analysis, by Company, 2020

    14.3. Company Profiles

        14.3.1. ANZCO Foods (Bovogen Biologicals Pvt. Ltd.)

            14.3.1.1. Company Overview

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. Business Strategies

            14.3.1.5. Recent Developments

        14.3.2. ATCC

            14.3.2.1. Company Overview

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. Business Strategies

            14.3.2.5. Recent Developments

        14.3.3. Bio-techne (Atlanta Biologicals, Inc.)

            14.3.3.1. Company Overview

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. Business Strategies

            14.3.3.5. Recent Developments

        14.3.4. Captivate Bio

            14.3.4.1. Company Overview

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. Business Strategies

            14.3.4.5. Recent Developments

        14.3.5. Danaher (Cytiva)

            14.3.5.1. Company Overview

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. Business Strategies

            14.3.5.5. Recent Developments

        14.3.6. HiMedia Laboratories

            14.3.6.1. Company Overview

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. Business Strategies

            14.3.6.5. Recent Developments

        14.3.7. Merck KGaA

            14.3.7.1. Company Overview

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. Business Strategies

            14.3.7.5. Recent Developments

        14.3.8. Pan Biotech GmbH

            14.3.8.1. Company Overview

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. Business Strategies

            14.3.8.5. Recent Developments

        14.3.9. Rocky Mountain Biologicals

            14.3.9.1. Company Overview

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. Business Strategies

            14.3.9.5. Recent Developments

        14.3.10. TCS Biosciences Ltd.

            14.3.10.1. Company Overview

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. Business Strategies

            14.3.10.5. Recent Developments

        14.3.11. Thermo Fisher Scientific Inc.

            14.3.11.1. Company Overview

            14.3.11.2. Financial Overview

            14.3.11.3. Product Portfolio

            14.3.11.4. Business Strategies

            14.3.11.5. Recent Developments

        14.3.12. Zen-Bio, Inc.

            14.3.12.1. Company Overview

            14.3.12.2. Financial Overview

            14.3.12.3. Product Portfolio

            14.3.12.4. Business Strategies

            14.3.12.5. Recent Developments

List of Tables

Table 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 02: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 06: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 09: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 18: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 02: Global Fetal Bovine Serum Market Value Share (%), by Region, 2020

Figure 03: Global Fetal Bovine Serum Market Value Share (%), by Application, 2020

Figure 04: Global Fetal Bovine Serum Market Value Share (%), by End-user, 2020

Figure 05: Global Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031

Figure 06: Global Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031

Figure 07: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Drug Discovery, 2017–2031

Figure 08: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Cell Media Culture, 2017–2031

Figure 09: Global Fetal Bovine Serum Market Revenue (US$ Mn), by In Vitro Fertilization, 2017–2031

Figure 10: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Human & Animal Vaccine Production, 2017–2031

Figure 11: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Diagnostics, 2017–2031

Figure 12: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Others, 2017–2031

Figure 13: Global Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031

Figure 14: Global Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031

Figure 15: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Research & Academic Institutes, 2017–2031

Figure 16: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Industry, 2017–2031

Figure 17: Global Fetal Bovine Serum Market Revenue (US$ Mn), by Healthcare Facilities, 2017–2031

Figure 18: Global Fetal Bovine Serum Market Value Share Analysis

Figure 19: Global Fetal Bovine Serum Market Attractiveness Analysis, by Region, 2021–2031

Figure 20: North America Fetal Bovine Serum Market Value Share Analysis, by Country, 2020 and 2031

Figure 21: North America Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 22: North America Fetal Bovine Serum Market Attractiveness Analysis, by Country, 2021–2031

Figure 23: North America Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031

Figure 24: North America Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031

Figure 25: Europe Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 20201–2031

Figure 26: Europe Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 27: Europe Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031

Figure 28: Europe Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031

Figure 29: Europe Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031

Figure 30: Europe Fetal Bovine Serum Market Attractiveness Index Analysis, by End-user, 2021–2031

Figure 31: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 32: Asia Pacific Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 33: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 34: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031

Figure 35: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031

Figure 36: Asia Pacific Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031

Figure 37: Asia Pacific Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031

Figure 38: Latin America Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 39: Latin America Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 40: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 41: Latin America Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031

Figure 42: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031

Figure 43: Latin America Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031

Figure 44: Latin America Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031

Figure 45: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 46: Middle East & Africa Fetal Bovine Serum Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 47: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 48: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by Application, 2020 and 2031

Figure 49: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by Application, 2021–2031

Figure 50: Middle East & Africa Fetal Bovine Serum Market Value Share Analysis, by End-user, 2020 and 2031

Figure 51: Middle East & Africa Fetal Bovine Serum Market Attractiveness Analysis, by End-user, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Fetal Bovine Serum Market